Table 4.
Visually significant postoperative CMEd (n = 1429a) | |
Cases with visually significant CME at Days 14–21 or 90 [n (%)] | 28 (2.0) |
Cases that received medication for CME at Days 14–21 or 90 | 22/28 (78.6) |
Concomitant conditions (cases with CME/total eyes) | |
Diabetes | 12/448 |
Epiretinal membrane | 2/11b |
Medications prescribed | |
Total | 32c |
Corticosteroid | 12 |
Nonsteroidal anti-inflammatory | 20 |
CME, cystoid macular edema.
aA total of 112 cases did not return for follow-up at Days 14–21.
bStatistically significantly different from the proportion of cases without the corresponding concomitant condition in the overall case set (n = 1429), chi-squared test.
cSome cases received more than one medication, so the number of medications differs from the number of cases that received medication.
dOnly includes cases of visually significant CME that emerged after cataract surgery. Excludes cases of CME that were present before surgery or at preoperative evaluation.